search
Back to results

Nexium Dyspepsia/AST

Primary Purpose

Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Esomeprazole
Sponsored by
AstraZeneca
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gastrointestinal Disease

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: At least 3 months of symptoms of pain or burning centered in the upper abdomen prior to enrollment. Helicobacter pylori test performed at enrollment must be negative (Helicobacter pylori is a bacterial infection of the stomach). Exclusion Criteria: Patients with symptoms of other gastrointestinal diseases, such as Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease (IBD). Helicobacter pylori eradication treatment during the last 12 months prior to enrollment.

Sites / Locations

  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site

Outcomes

Primary Outcome Measures

The primary outcome is whether the patient is a responder or not after 8 weeks treatment.
The primary efficacy outcome is based on symptom score recorded daily during the study in a patient diary.
The patient will judge their symptoms of pain or burning centered in the upper abdomen on a four-graded scale (none, mild, moderate or severe).

Secondary Outcome Measures

The secondary efficacy outcomes are whether the patient is a responder or not after 4 weeks,
The average symptom score and the percentage of symptom-free days during the 7-week treatment period,
Presence/absence of specific GI symptoms after 4 and 8 weeks of therapy

Full Information

First Posted
November 9, 2005
Last Updated
January 21, 2011
Sponsor
AstraZeneca
search

1. Study Identification

Unique Protocol Identification Number
NCT00251992
Brief Title
Nexium Dyspepsia/AST
Official Title
Supportive Test for Acid-Related Symptoms (STARS II) With Esomeprazole and a Following 7-week, Double-blind, Randomized, Placebo Controlled Treatment Period in Uninvestigated Subjects With Upper Gastrointestinal Symptoms.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2011
Overall Recruitment Status
Completed
Study Start Date
December 2002 (undefined)
Primary Completion Date
January 2005 (Actual)
Study Completion Date
January 2005 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
AstraZeneca

4. Oversight

5. Study Description

Brief Summary
The aim is to evaluate if the resolution of upper abdominal symptoms (pain or burning) during an acid suppressive test trial of esomprazole given daily for 7 days predicts symptoms resolution at the end of a subsequent treatment period of 7 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
1200 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Esomeprazole
Primary Outcome Measure Information:
Title
The primary outcome is whether the patient is a responder or not after 8 weeks treatment.
Title
The primary efficacy outcome is based on symptom score recorded daily during the study in a patient diary.
Title
The patient will judge their symptoms of pain or burning centered in the upper abdomen on a four-graded scale (none, mild, moderate or severe).
Secondary Outcome Measure Information:
Title
The secondary efficacy outcomes are whether the patient is a responder or not after 4 weeks,
Title
The average symptom score and the percentage of symptom-free days during the 7-week treatment period,
Title
Presence/absence of specific GI symptoms after 4 and 8 weeks of therapy

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: At least 3 months of symptoms of pain or burning centered in the upper abdomen prior to enrollment. Helicobacter pylori test performed at enrollment must be negative (Helicobacter pylori is a bacterial infection of the stomach). Exclusion Criteria: Patients with symptoms of other gastrointestinal diseases, such as Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease (IBD). Helicobacter pylori eradication treatment during the last 12 months prior to enrollment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
AstraZeneca Nexium Medical Sciences Director, MD
Organizational Affiliation
AstraZeneca
Official's Role
Study Director
Facility Information:
Facility Name
Research Site
City
Braunau
Country
Austria
Facility Name
Research Site
City
Graz
Country
Austria
Facility Name
Research Site
City
Krems
Country
Austria
Facility Name
Research Site
City
Linz
Country
Austria
Facility Name
Research Site
City
Salzburg
Country
Austria
Facility Name
Research Site
City
Sankt Pölten
Country
Austria
Facility Name
Research Site
City
St. Johann
Country
Austria
Facility Name
Research Site
City
Wiener Neustadt
Country
Austria
Facility Name
Research Site
City
Wien
Country
Austria
Facility Name
Research Site
City
Zell am See
Country
Austria
Facility Name
Research Site
City
Ans
Country
Belgium
Facility Name
Research Site
City
Brussels (Uccle)
Country
Belgium
Facility Name
Research Site
City
Gozée
Country
Belgium
Facility Name
Research Site
City
Halle
Country
Belgium
Facility Name
Research Site
City
Kontich
Country
Belgium
Facility Name
Research Site
City
Kortenberg
Country
Belgium
Facility Name
Research Site
City
Kraainem
Country
Belgium
Facility Name
Research Site
City
Linkebeek
Country
Belgium
Facility Name
Research Site
City
Liège
Country
Belgium
Facility Name
Research Site
City
Massemen
Country
Belgium
Facility Name
Research Site
City
Moerkerke
Country
Belgium
Facility Name
Research Site
City
Natoye
Country
Belgium
Facility Name
Research Site
City
Oud-Heverlee
Country
Belgium
Facility Name
Research Site
City
Saint-Médard
Country
Belgium
Facility Name
Research Site
City
Soignies
Country
Belgium
Facility Name
Research Site
City
Waremme
Country
Belgium
Facility Name
Research Site
City
Wezembeek- Oppem
Country
Belgium
Facility Name
Research Site
City
Wingene
Country
Belgium
Facility Name
Research Site
City
Zoersel
Country
Belgium
Facility Name
Research Site
City
Zolder
Country
Belgium
Facility Name
Research Site
City
Zonhoven
Country
Belgium
Facility Name
Research Site
City
Calgary
State/Province
Alberta
Country
Canada
Facility Name
Research Site
City
Edmonton
State/Province
Alberta
Country
Canada
Facility Name
Research Site
City
Kelowna
State/Province
British Columbia
Country
Canada
Facility Name
Research Site
City
Penticton
State/Province
British Columbia
Country
Canada
Facility Name
Research Site
City
Winnipeg
State/Province
Manitoba
Country
Canada
Facility Name
Research Site
City
Bay Roberts
State/Province
Newfoundland and Labrador
Country
Canada
Facility Name
Research Site
City
St. John's
State/Province
Newfoundland and Labrador
Country
Canada
Facility Name
Research Site
City
Elmsdale
State/Province
Nova Scotia
Country
Canada
Facility Name
Research Site
City
Halifax
State/Province
Nova Scotia
Country
Canada
Facility Name
Research Site
City
Ajax
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Brampton
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Burlington
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Dorchester
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Hamilton
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Kanata
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Kitchener
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
London
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Markham
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Mississauga
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Niagara Falls
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
North York
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Orleans
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Oshawa
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Ottawa
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Richmond Hill
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Sainte Gedeon-de-Beauce
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Scarborough
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
St Catherines
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Stirling
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Thunder Bay
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Toronto
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Tottenham
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Whitby
State/Province
Ontario
Country
Canada
Facility Name
Research Site
City
Charlottetown
State/Province
Prince Edward Island
Country
Canada
Facility Name
Research Site
City
Parkdale
State/Province
Prince Edward Island
Country
Canada
Facility Name
Research Site
City
Charlesbourg
State/Province
Quebec
Country
Canada
Facility Name
Research Site
City
Granby
State/Province
Quebec
Country
Canada
Facility Name
Research Site
City
Saint-Leonard
State/Province
Quebec
Country
Canada
Facility Name
Research Site
City
Sainte-Foy
State/Province
Quebec
Country
Canada
Facility Name
Research Site
City
Espoo
Country
Finland
Facility Name
Research Site
City
Helsinki
Country
Finland
Facility Name
Research Site
City
Kouvola
Country
Finland
Facility Name
Research Site
City
Lempäälä
Country
Finland
Facility Name
Research Site
City
Pirkkala
Country
Finland
Facility Name
Research Site
City
Pori
Country
Finland
Facility Name
Research Site
City
Sahalahti
Country
Finland
Facility Name
Research Site
City
Tampere
Country
Finland
Facility Name
Research Site
City
Vääksy
Country
Finland
Facility Name
Research Site
City
Angers
Country
France
Facility Name
Research Site
City
Dambach La Ville
Country
France
Facility Name
Research Site
City
Dijon
Country
France
Facility Name
Research Site
City
La Seyne Sur Mer
Country
France
Facility Name
Research Site
City
Laxou
Country
France
Facility Name
Research Site
City
Louviers
Country
France
Facility Name
Research Site
City
MONT DE MARSAN Cedex
Country
France
Facility Name
Research Site
City
NANCY Cedex
Country
France
Facility Name
Research Site
City
Saint-ouen
Country
France
Facility Name
Research Site
City
Vieux Conde
Country
France
Facility Name
Research Site
City
Lochham
Country
Germany
Facility Name
Research Site
City
München
Country
Germany
Facility Name
Research Site
City
Rödental
Country
Germany
Facility Name
Research Site
City
Budapest
Country
Hungary
Facility Name
Research Site
City
Budaörs
Country
Hungary
Facility Name
Research Site
City
Esztergom
Country
Hungary
Facility Name
Research Site
City
Hatvan
Country
Hungary
Facility Name
Research Site
City
Nagykanizsa
Country
Hungary
Facility Name
Research Site
City
Siófok
Country
Hungary
Facility Name
Research Site
City
Tát
Country
Hungary
Facility Name
Research Site
City
Zalaegerszeg
Country
Hungary
Facility Name
Research Site
City
Mexico
State/Province
D.F
Country
Mexico
Facility Name
Research Site
City
Culiacán
Country
Mexico
Facility Name
Research Site
City
Guadalajara
Country
Mexico
Facility Name
Research Site
City
León
Country
Mexico
Facility Name
Research Site
City
México
Country
Mexico
Facility Name
Research Site
City
Torreón
Country
Mexico
Facility Name
Research Site
City
Bekkestua
Country
Norway
Facility Name
Research Site
City
Bergen
Country
Norway
Facility Name
Research Site
City
Hønefoss
Country
Norway
Facility Name
Research Site
City
Lier
Country
Norway
Facility Name
Research Site
City
Lysaker
Country
Norway
Facility Name
Research Site
City
Moss
Country
Norway
Facility Name
Research Site
City
Oslo
Country
Norway
Facility Name
Research Site
City
Paradis
Country
Norway
Facility Name
Research Site
City
Rykkinn
Country
Norway
Facility Name
Research Site
City
Rådal
Country
Norway
Facility Name
Research Site
City
Sandefjord
Country
Norway
Facility Name
Research Site
City
Skien
Country
Norway
Facility Name
Research Site
City
Søgne
Country
Norway
Facility Name
Research Site
City
Tvedestrand
Country
Norway
Facility Name
Research Site
City
Østerås
Country
Norway
Facility Name
Research Site
City
Lenasia
State/Province
Gauteng
Country
South Africa
Facility Name
Research Site
City
Bloemfontein
Country
South Africa
Facility Name
Research Site
City
Boksburg
Country
South Africa
Facility Name
Research Site
City
Cape Town
Country
South Africa
Facility Name
Research Site
City
Durban
Country
South Africa
Facility Name
Research Site
City
Halfway House
Country
South Africa
Facility Name
Research Site
City
Lyttelton Manor
Country
South Africa
Facility Name
Research Site
City
Pretoria
Country
South Africa
Facility Name
Research Site
City
Fritsla
Country
Sweden
Facility Name
Research Site
City
Göteborg
Country
Sweden
Facility Name
Research Site
City
Halmstad
Country
Sweden
Facility Name
Research Site
City
Höganäs
Country
Sweden
Facility Name
Research Site
City
Ingelstad
Country
Sweden
Facility Name
Research Site
City
Jönköping
Country
Sweden
Facility Name
Research Site
City
Kalmar
Country
Sweden
Facility Name
Research Site
City
Kilafors
Country
Sweden
Facility Name
Research Site
City
Kristinehamn
Country
Sweden
Facility Name
Research Site
City
Kungsör
Country
Sweden
Facility Name
Research Site
City
Motala
Country
Sweden
Facility Name
Research Site
City
Munkedal
Country
Sweden
Facility Name
Research Site
City
Norrtälje
Country
Sweden
Facility Name
Research Site
City
Nässjö
Country
Sweden
Facility Name
Research Site
City
Rättvik
Country
Sweden
Facility Name
Research Site
City
Staffanstorp
Country
Sweden
Facility Name
Research Site
City
Sundsbruk
Country
Sweden
Facility Name
Research Site
City
Trollhättan
Country
Sweden
Facility Name
Research Site
City
Uddevalla
Country
Sweden
Facility Name
Research Site
City
Upplands Väsby
Country
Sweden
Facility Name
Research Site
City
Vällingby
Country
Sweden
Facility Name
Research Site
City
Västerås
Country
Sweden
Facility Name
Research Site
City
Växjö
Country
Sweden
Facility Name
Research Site
City
Ängelholm
Country
Sweden
Facility Name
Research Site
City
Schönbühl-Urtenen
State/Province
Bern
Country
Switzerland
Facility Name
Research Site
City
Egg bei Zürich
State/Province
Zürich
Country
Switzerland
Facility Name
Research Site
City
Winterthur
State/Province
Zürich
Country
Switzerland
Facility Name
Research Site
City
Aarau
Country
Switzerland
Facility Name
Research Site
City
Brittnau
Country
Switzerland
Facility Name
Research Site
City
Küttigen
Country
Switzerland
Facility Name
Research Site
City
Schaffhausen
Country
Switzerland
Facility Name
Research Site
City
Zürich
Country
Switzerland
Facility Name
Research Site
City
Ely
State/Province
Cambridgeshire
Country
United Kingdom
Facility Name
Research Site
City
Woking
State/Province
Surrey
Country
United Kingdom
Facility Name
Research Site
City
Audley
Country
United Kingdom
Facility Name
Research Site
City
Blackburn
Country
United Kingdom
Facility Name
Research Site
City
Blackpool
Country
United Kingdom
Facility Name
Research Site
City
Chesterfield
Country
United Kingdom
Facility Name
Research Site
City
Coventry
Country
United Kingdom
Facility Name
Research Site
City
Enfield
Country
United Kingdom
Facility Name
Research Site
City
Glasgow
Country
United Kingdom
Facility Name
Research Site
City
Hadleigh
Country
United Kingdom
Facility Name
Research Site
City
Harrow
Country
United Kingdom
Facility Name
Research Site
City
Irvine
Country
United Kingdom
Facility Name
Research Site
City
Mansfield
Country
United Kingdom
Facility Name
Research Site
City
Nottingham
Country
United Kingdom
Facility Name
Research Site
City
Sheffield
Country
United Kingdom
Facility Name
Research Site
City
Shrewsbury
Country
United Kingdom
Facility Name
Research Site
City
Slough
Country
United Kingdom
Facility Name
Research Site
City
Titchfield
Country
United Kingdom
Facility Name
Research Site
City
Tonbridge
Country
United Kingdom
Facility Name
Research Site
City
Tunbridge Wells
Country
United Kingdom
Facility Name
Research Site
City
Watford
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
21848799
Citation
van Zanten SV, Wahlqvist P, Talley NJ, Halling K, Vakil N, Lauritsen K, Flook N, Persson T, Bolling-Sternevald E; STARS II Investigators. Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study. Aliment Pharmacol Ther. 2011 Oct;34(7):714-23. doi: 10.1111/j.1365-2036.2011.04789.x. Epub 2011 Aug 17.
Results Reference
derived
PubMed Identifier
17697200
Citation
van Zanten SV, Flook N, Talley NJ, Vakil N, Lauritsen K, Bolling-Sternevald E, Persson T, Bjorck E, Svedberg LE; STARS II Study Group. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther. 2007 Sep 1;26(5):665-72. doi: 10.1111/j.1365-2036.2007.03409.x.
Results Reference
derived

Learn more about this trial

Nexium Dyspepsia/AST

We'll reach out to this number within 24 hrs